Lipoprotein(a) apolipoprotein B and LDL-cholesterol concentration in children with and without family history of atherosclerosis.: Effect of Lp(a) cholesterol on C-LDL values.

被引:0
|
作者
Sellés, J
Coniglio, RI
Alvarez, C
Benozzi, S
机构
[1] Univ Sur, Dept Biol Bioquim & Farm, Catedra Anal Clin 2, Bahia Blanca, Buenos Aires, Argentina
[2] Ctr Invest Biomed, Viedma, Argentina
来源
关键词
atherosclerosis; lipoprotein(a); apolipoprotein B; LDL cholesterol; children; family history of atherosclerosis;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The aim of this study was: a) to assess the prevalence in children of elevated Lipoprotein (a) concentration alone, or associated with serum Apolipoprotein B (Apo B) and LDL-Cholesterol (LDL-C), and b) to evaluate the effect of LDL-C correction for Lp(a)-Cholesterol (Lp(a)-C) on the prevalence of hipercholesterolemia in the population studied. Total cholesterol (TC), LDL-C, Apo B, Lp(a) and Lp(a)-C were determined in a group of 126 children aged 12-14 years. The means values observed were: TC, 166 +/- 33 mg/dl (4.30 +/- 0.85 mmol/l); LDL-C 97 +/- 30 mg/dl (2.51 +/- 0.78 mmol/l); Apo B 88 +/- 26 mg/dl; mediana Lp(a), 10 mg/dl (percentil 75, 34 mg/dl). No significant sex-related differences were observed. The children were divided in 2 subgroups according to their family history of atherosclerosis (FH) in parents or/and grandparents. In 57 children with FH, mean serum TC concentration was 173 +/- 38 mg/dl (4.48 +/- 0.98 mmol/l) vs. 161 +/- 27 mg/dl (4.17 +/- 0.67 mmol/l) found in 69 children without FH (p < 0.05). No significant difference was founded between subgroups in LDL-C and Apo B levels, as well as in the prevalence of children with TC < 200 mg/dl (5.17 mmol/l) and LDL-C > 130 mg/dl (3.37 mmol/l) (15.8% vs. 11.6% and 17.5% vs. 13%); LDL-C < 111 mg/dl (2.88 mmol/l) and Apo B > 101 mg/dl (14% vs. 7.2%; p = 0.21); Apo B > 120 mg/dl (14% vs. 5.8%; p = 0.11); Lp(a) > 30 mg/dl (33.3% vs. 27.5%, ns); Lp(a) > 30 mg/dl and LDL-C > 130 mg/dl (7.3% vs 2.9%, ns); Lp(a) > 30 mg/dl and Apo B > 101 mg/dl (3.5% vs. 2.9%, ns). The combination of Lp(a) > 30 mg/dl anal LDL-C > 130 mg/dl or Apo B > 115 mg/dl was present only in the 7% of the children, independently of their FH. Correction of LDL-values for Lp(a)-C did not modified hipercholesterolemia prevalence.
引用
收藏
页码:339 / 349
页数:11
相关论文
共 25 条
  • [1] APOLIPOPROTEIN B VERSUS LDL-CHOLESTEROL: ASSOCIATION WITH OTHER RISK FACTORS FOR ATHEROSCLEROSIS
    Vaverkova, H.
    Karasek, D.
    Novotny, D.
    Jackuliakova, D.
    Lukes, J.
    Frohlich, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [2] Apolipoprotein B versus LDL-cholesterol: Association with other risk factors for atherosclerosis
    Vaverkova, Helena
    Karasek, David
    Novotny, Dalibor
    Jackuliakova, Dagmar
    Lukes, Jiri
    Halenka, Milan
    Frohlich, Jiri
    CLINICAL BIOCHEMISTRY, 2009, 42 (12) : 1246 - 1251
  • [3] The effect of LDL-cholesterol on serum Lipoprotein(a) concentration in liver cirrhosis.
    Chun, S
    Min, W
    Choi, S
    Chung, Y
    Park, H
    Chi, H
    CLINICAL CHEMISTRY, 2000, 46 (06) : A95 - A95
  • [4] Apolipoprotein B: A preferable measure to LDL-cholesterol in hypertriglyceridaemic patients undergoing lipoprotein apheresis
    Neves, E.
    Ussen, B.
    Kale, V.
    Bourdeaux, N.
    Calam, M.
    Huggett, C.
    Lee, E.
    Pottle, A.
    Barbir, M.
    ATHEROSCLEROSIS, 2011, 218 (02) : E7 - E7
  • [5] CHANGES IN LIPOPROTEIN(A), LDL-CHOLESTEROL AND APOLIPOPROTEIN-B IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIC PATIENTS TREATED WITH DEXTRAN SULFATE LDL-APHERESIS
    LASUNCION, MA
    TERUEL, JL
    ALVAREZ, JJ
    CARRERO, P
    ORTUNO, J
    GOMEZCORONADO, D
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1993, 23 (12) : 819 - 826
  • [6] THE EFFECT OF APOLIPOPROTEIN-E ISOFORM DIFFERENCE ON POSTPRANDIAL LIPOPROTEIN COMPOSITION IN PATIENTS MATCHED FOR TRIGLYCERIDES, LDL-CHOLESTEROL, AND HDL-CHOLESTEROL
    SUPERKO, HR
    HASKELL, WL
    ARTERY, 1991, 18 (06) : 315 - 325
  • [7] Effect of weight loss with orlistat in patients with elevated LDL-cholesterol (LDL-C) with and without high triglycerides (Tg)
    Reaven, G
    Lucas, C
    Boldrin, M
    Segal, KR
    Hauptman, J
    EUROPEAN HEART JOURNAL, 2000, 21 : 438 - 438
  • [8] APOLIPOPROTEIN B AND NON-HDL-CHOLESTEROL BETTER REFLECT RESIDUAL RISK THAN LDL-CHOLESTEROL IN STATIN-TREATED PATIENTS WITH ATHEROSCLEROSIS
    Johannesen, C. D. L.
    Langsted, A.
    Nordestgaard, B. G.
    Mortensen, M. B.
    ATHEROSCLEROSIS, 2021, 331 : E46 - E46
  • [9] Effect of mipomersen on LDL-cholesterol in patients with severe LDLhypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis (The MICA-Study)
    Waldmann, Elisa
    Vogt, Anja
    Crispin, Alexander
    Altenhofer, Julia
    Riks, Ina
    Parhofer, Klaus G.
    ATHEROSCLEROSIS, 2017, 259 : 20 - 25
  • [10] DISCORDANCE BETWEEN APOLIPOPROTEIN B AND LDL-CHOLESTEROL AND HYPERTENSION RISK AMONG ADULTS WITH AND WITHOUT TYPE 2 DIABETES
    Zeng, Ni
    Lavelle, Kevin
    Manjelievskaia, Janna
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1715 - 1715